New injection aims to tame dangerous fat levels in rare disorder
NCT ID NCT05902598
Summary
This study tested an experimental injection called Plozasiran in Chinese adults with familial chylomicronemia syndrome (FCS), a rare genetic disorder that causes extremely high levels of fat in the blood. The main goal was to see if the injection could safely and effectively lower these fat levels over a long period. For about two years, 37 participants received either the real injection or a placebo (dummy shot) without knowing which one they got.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL CHYLOMICRONEMIA SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.